购物车
- 全部删除
- 您的购物车当前为空
AZD-9164,一种muscarinic M3 receptor antagonist,被开发用于治疗慢性阻塞性肺病(COPD)。AZD-9164旨在通过改善肺功能的幅度和持久性而不增加系统性不良事件,可能超越tiotropium的治疗指数。
AZD-9164,一种muscarinic M3 receptor antagonist,被开发用于治疗慢性阻塞性肺病(COPD)。AZD-9164旨在通过改善肺功能的幅度和持久性而不增加系统性不良事件,可能超越tiotropium的治疗指数。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | AZD-9164, a muscarinic M3 receptor antagonist, is developed for potential use in treating chronic obstructive pulmonary disease. It is anticipated that AZD-9164 could surpass tiotropium's therapeutic index by enhancing both the extent and persistence of pulmonary function improvements, while not amplifying systemically-mediated adverse events. |
别名 | J3.232.015E, CHEMBL1921904, AZD9164, 977LWC4O5D |
分子量 | 465.62 |
分子式 | C29H38FN2O2 |
CAS No. | 1034978-04-5 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容